Skip to Main Content

Paper Details

Impact of high-risk prenatal screening results for 22q11.2 deletion syndrome on obstetric and neonatal management: Secondary analysis from the SMART study.
Prenat Diagn
0
2023
22q11, Patients, calcium, cfDNA, infant, infants, lymphocyte, participants
Author NameAffiliation
Ronald J WapnerColumbia Presbyterian Medical Center
Hakon HakonarsonCenter for Applied Genomics, Children's Hospital of Philadelphia
Hakon HakonarsonCenter for Applied Genomics, Children's Hospital of Philadelphia
  • 1 - 3

Datasets

Release 1.2